Status:
UNKNOWN
Pancreatic Exocrine Insufficiency After Bariatric Surgery
Lead Sponsor:
Umraniye Education and Research Hospital
Conditions:
Obesity, Morbid
Pancreatic Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
Main proposed benefit of sleeve gastrectomy is loss of ghrelin secreting tissue. Some studies express that ghrelin augment pancreatic regeneration. Therefore we hypothesized that with sleeve gastrecto...
Detailed Description
Mechanism of weight loss differs in bariatric surgery according to type of surgery. With sleeve gastrectomy which has restrictive mechanism, ghrelin excretion decreases, and this condition is attribu...
Eligibility Criteria
Inclusion
- Patients underwent bariatric surgery (Sleeve gastrectomy) after concordonce with NIH criteria
Exclusion
- Additional operations to sleeve gastrectomy like duodenal switch. Other bariatric operations.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03279653
Start Date
September 1 2017
End Date
December 1 2018
Last Update
September 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umraniye Education and Research Hospital
Istanbul, Ümraniye, Turkey (Türkiye), 34000